| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b05abbf4c8360f1d24d6fbbc47dc544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4e19677667c99069b958e8686a1760c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a82352dfcffc3685c9ba17a9bd14892 |
| publicationDate |
2020-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3679029-A1 |
| titleOfInvention |
Imidazolidine compounds |
| abstract |
The present invention relates to a compound of formula I wherein X is selected from the group consisting of (CH2) 2- and CH2-CH (CH3) -; Q is selected from the group consisting of C (CH3) 2 and; or a pharmaceutically acceptable salt thereof; the invention also relates to compositions, methods of treating liver disease and NASH. |
| priorityDate |
2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |